In this podcast, Dr. Rijneveld discusses BCR-ABL1-like acute lymphoblastic leukemia (ALL), a specific subgroup of ALL characterized by an expression profile similar to Ph+ ALL, albeit lacking the BCR-ABL1 rearrangement, and by sensitivity to TKIs. She highlights how TKIs were game-changing for the prognostic of these patients, although their cost and associated toxicities (usually low but fatiguing in the long-term), may still be issues in the clinical practice.Interview with: Anita Rijneveld. Host: Shaun McCannWhat did you think of this podcast? Share your opinions with us in this short feedback survey.Provide FeedbackWould you like to receive EBAH CME credit points for listening to podcasts? Please visit the EHA Campus and check out the EHA Unplugged catalog.https://ehacampus.ehaweb.org/Subscribe, share, and review this podcast to be able to address topics you enjoy and like to listen to.Follow EHA on Instagram: https://www.instagram.com/EHA_Hematology/Facebook: https://e-h-a.link/facebookLinkedIn: https://www.linkedin.com/company/eha/Email us:  [email protected] to receive the EHA Educational Updates via https://eha.news/subscribe

Ver todos los episodios